Drug Research

The FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After having to retract its contentious 2021 approval of Biogen's Aduhelm Alzheimer's disease medication, has the FDA grown timid? The incident...

A technique created by Karolinska Institutet researchers should be able to forecast whether a breast cancer patient will benefit from a specific treatment or not. According to a study that was published in PNAS, the cell-based approach has been...

Researchers at UCSF have developed a novel, potentially life-saving technique that may prevent antibodies from prompting the immune system to reject specifically tailored therapeutic and transplant cells. It has been particularly difficult to cure rejection caused by antibodies as opposed...

Polarean Imaging plc, the medical imaging technology company, announces that the US Food and Drug Administration (FDA) has granted approval for its drug device combination product, Xenoview. Xenoview, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast...

PeptiDream Inc., a Japan-based biopharmaceutical company, has entered a new multi-target collaboration and license agreement with Merck & Co, Inc. (known as MSD outside the U.S.) focused on the discovery and development of novel peptide drug conjugates (PDCs). PeptiDream will...

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, began the first phase of operations at its global manufacturing site dedicated to mRNA vaccine production in Jiashan, Zhejiang Province. The first phase...

The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was released recently in the New England Journal of Medicine. This finding will help with the diagnosis and open up...